News
05-14-2011, 01:04 AM
The possibility of low-dose Molecular Breast Imaging (MBI) looks promising according to the most recent clinical evidence revealed this past month at the National Institutes of Health (NIH). Dr. Marcela Bohm-Velez and her colleagues from Associates in Pittsburgh, Pa...
More... (http://www.medicalnewstoday.com/releases/225308.php)
More... (http://www.medicalnewstoday.com/releases/225308.php)